News
Alivus Life Sciences standalone net profit rises 31.71% in the June 2026 quarter
31-Jul-2026 | 07:38
Sales rise 6.41% to Rs 640.41 crore
Net profit of Alivus Life Sciences rose 31.71% to Rs 160.08 crore in the quarter ended June 2026 as against Rs 121.54 crore during the previous quarter ended June 2025. Sales rose 6.41% to Rs 640.41 crore in the quarter ended June 2026 as against Rs 601.85 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 640.41 | 601.85 | 6 |
| OPM % | 33.06 | 28.63 | - |
| PBDT | 232.81 | 180.05 | 29 |
| PBT | 212.22 | 162.99 | 30 |
| NP | 160.08 | 121.54 | 32 |
Powered by Capital Market - Live News